MGL-3196 Synthesis
MGL-3196 (Synonyms: 2-[3,5-Dichloro-4-[[1,6-dihydro-5-(1-methylethyl)-6-oxo-3-pyridazinyl]oxy]phenyl]-2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazine-6-carbonitrile)
The renaming of NAFLD to MASLD and NASH to MASH emphasizes the metabolic dysregulation underlying these steatotic liver diseases.
MGL-3196
An agonist of TRβ
Item No. AX18166
CAS No. 920509-32-6
Purity: 95%
MGL-3196 Synthetic Route
1.1: potassium carbonate; copper(l) iodide / dimethyl sulfoxide / 24 h / 20 - 90 °C / Inert atmosphere
2.1: acetic acid; sodium acetate / 24 h / 100 °C / Inert atmosphere
2.2: 24 h / 120 °C / Inert atmosphere
3.1: sodium nitrate; hydrogenchloride / water / 0.5 h / 0 °C
3.2: 0 °C
4.1: acetic acid; sodium acetate / 1.5 h / 20 - 120 °C / Inert atmosphere
Order MGL-3196 Intermediates
References
1.Journal of Medicinal Chemistry, 2014, vol. 57, # 10, p. 3912 – 3923
1Kelly, M.J., Pietranico-Cole, S., Larigan, J.D., et al. Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a highly selective thyroid hormone receptor β agonist in clinical trials for the treatment of dyslipidemia. J. Med. Chem. 57(10), 3912-3923 (2014).
Catalog No. {{modalData.supplierPartNo}}
CAS:{{modalData.cas}}
{{sku['packsize']}}{{sku['packunit']}}
${{getUSMoneyFormat(sku['price'])}}
Buy Now